SUMMARY In an experimental jejunal perfusion study, distress in healthy subjects occurred during eight out of 16 perfusions in which intestinal secretion was provoked. Calculation demonstrates the volumetric consequences of inadequate recovery of secretory perfusates, and analysis of the perfusion studies shows that distress was significantly associated with poor recovery of the perfusate. These observations are pertinent to increasing interest in the phenomenon of intestinal fluid secretion.
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The development of intestinal intubation techniques since the work of Abbott and Miller (1936) has allowed extensive study of intestinal absorption in man. Until recent years, such perfusion studies have usually involved the perfusion of physiological electrolytes or nutrients into the intestine (Fordtran and Ingelfinger, 1968) , and hazards associated with such perfusions have been rarely reported. Even the use of balloons obstructing the lumen of the intestine seems to be a safe procedure except in the presence of intestinal disease (Schmid, Phillips, and Summerskill, 1968) although pancreatic duct obstruction by the balloon has occurred (J. R. Malagelada, personal communication). Recently, there has been interest in the perfusion of solutes which, at low concentrations, inhibit intestinal water absorption or provoke intestinal water secretion; such substances include laxatives, hydroxy fatty acids, and bile acids. In a recent study of the effect of glycine-conjugated bile acids on jejunal absorption in man (Wingate, Phillips, and Hofmann, 1973) , it was briefly reported that perfusions of bile acids which induced net secretion were in some cases associated with unpleasant symptoms in healthy subjects. However, further instances of adverse effects from perfusions with bile acids (E. Krag and S. F. Phillips, personal communication), bisacodyl (P. Czybylski and K. Ewe, personal communication) and prostaglandins (C. Matuchansky, personal communication) have come to our attention, suggesting that this phenomenon is likely to occur in the presence of secretory perfusions. 
Methods
Proximal jejunal segments of healthy adult volunteers who had given informed consent were perfused with glucose electrolyte solutions containing 0, 2.5, 5 0, or 10.0 mM/l concentrations of glycine-conjugated bile acids, by a double-lumen technique (Phillips and Summerskill, 1968) . A detailed account of the solutions and methods employed has been given elsewhere (Wingate et al, 1973) . Each subject received four consecutive 90-minute perfusions, each perfusion containing one of the bile acid concentrations in a sequence determined by a Latin square design. The bile acids employed were glycocholic acid (GC), glycochenodeoxycholic acid (GCDC), and glycodeoxycholic acid (GDC). 1.9 ± 0.4 1.2 ± 0-2 1.1 ± 0-2 5-0 2-0 + 05 0-2 ± 0-2 -0-8 ± 0-2 10-0 1-7 ± 0-1 -1-3 ± 0-1 -2-3 ± 0-4 Since adverse effects only occurred with dihydroxy bile acid concentrations which arrested absorption or provoked net secretion, it was assumed that subjects who experienced discomfort would show greater net secretion rates. In fact, within experimental groups, there was no correlation between the magnitude of net secretion and the occurrence of adverse. effects. It was this latter finding that promptedl scrutiny of the variation in recovery of perfusates.
PERCENTAGE RECOVERY OF PERFUSATES
Percentage recoveries for perfusions of dlihydroxy bile acids in concentrations associated with adverse effects were calculated, and some significant differences were found between 'toxic' and 'non-toxic' perfusions. These are shown in table III. In this context, 'toxic' merely denotes the association of adverse effects with a perfusion.
A significant difference (p < 002) was found between recoveries of toxic and non-toxic perfusates. The data provide an explanation for the otherwise baffling phenomenon of toxicity with GCDC perfusates, when, as shown in table I, the effect of GCDC on absorption is less than that of GDC. Recovery of GCDC perfusates was, overall, significantly less than recovery of GDC perfusates. It is also clear that when toxicity was associated with 5 mM/l perfusates (in three perfusions) recovery was very poor. (Wingate et al, 1973) .
Discussion
The cause of the distress induced by dihydroxy bile acid perfusion in healthy subjects was at first obscure. Intraluminal conjugated bile acids are not recognized as a source of abdominal distress, and higher concentrations than those employed here may be found in the normal human intestinal lumen after gallbladder contraction. Reported effects in vitro of bile acids on enterocyte enzyme systems (Pope, Parkinson, and Olson, 1966; Hepner and Hofmann, 1973) do not appear to be of clinical significance. The symptoms experienced by the subjects were not sufficiently specific to indicate a precise pathophysiological origin. Since it was noted that symptoms were only associated with perfusates which either arrested net absorption or induced frank secretion, this prompted an analysis of the volume changes involved.
When a perfusate containing a non-absorbed secretogenic solute is used as a test solution in an intestinal perfusion system, and only partly recovered by siphonage at the end of the test segment, the residual solute will continue to induce secretion distal to the test segment. This distal secretion will continue until the solute is either diluted to a concentration (C') which does not provoke secretion, or removed from the lumen. The extreme case is shown by simple calculation. The data summarized in table I yield the information that C' for GDC is 4-3 mM/I.
If 10 ml/min of a 10 mM/1 solution of GDC is perfused into the intestine, and the GDC is neither absorbed nor inactivated, the volume will increase until 23 ml/min will pass a point distal to the perfusion point. The assumption underlying perfusion techniques is that distal recovery of the perfusate will prevent this volume expansion. The quantitative consequence of recovering less than 100% of a secretogenic perfusate is illustrated in figure 1 . In unit time, a volume Vin is perfused into the intestinal V.~. 
Vin() Figure I shows that in the presence of secretion, even when R = 100%, there is residual perfusate which will increase in volume in segment BC, and as R falls, Vi increases and exceeds Vin.
For comparison, fig 2 illustrates the same perfusion geometry during absorption; in this case, no perfusate will reach C until R falls well below 100 %. In this instance, the rate of volume change in AB and BC is constant; the problem of computing volume change in the presence of a secretogenic solute is that this is being constantly modified by dilution of the solute, and calculation of Vi must take account of this by solving differential equations for volume changes between AB and BC. Even if our hypothesis is correct, some questions remain to be answered. Since intestinal perfusion is not a new technique, why should fluid distension be a 'new' phenomenon ? It is possible that adverse effects of perfusion have occurred in the past, but have been attributed to idiosyncrasy or intolerance of intubation. A more probable explanation is to be found in the fact that the experimental use of perfusates containing secretogenic substances in human small intestine is a recent development. Allied to this, there has been an increasing tendency to perfuse the small intestine with a double-lumen system with an occlusive balloon (Phillips and Summerskill, 1966) rather than with a triple-lumen system with a mixing segment (Whalen, Harris, Geenan, and Soergel, 1966) . The controversy over the respective merits of the two systems has concentrated on their accuracy in measuring absorption (Sladen and Dawson, 1968; Fordtran, 1969; Sladen and Dawson, 1970; Modigliani and Bernier, 1971) . One difference between the two systems which has not so far received attention, probably because it was thought to be of little or no interest, is that the triple-lumen system has two siphonage tubes, compared to the single siphonage of the double-lumen system. It may be for this reason that Russell and his colleagues (Russell, Allan, Gerskowitch, and Cochran, 1973) apparently did not encounter adverse effects with bile acid perfusions similar to ours, since they combined the use of an occlusive balloon with a mixing segment and a triple-lumen perfusion system.
What significance should be attached to our findings? Our model demonstrates that secretogenic perfusions may generate substantial volumes of fluid in the lumen of the small intestine. Our hypothesis suggests that such volumes can cause discomfort in healthy subjects and also raises the possibility of hazard in the presence of intestinal disease. We conclude that when solutions are perfused into the small intestine in conditions associated with net fluid secretion, more attention should be paid to predicting the consequent volume changes in the intestine; in practical terms this means care in avoiding excess perfusion rates and ensuring adequate perfusate recovery.
